盐酸多奈哌齐片质量评价

doi:10.19803/j.1672-8629.20230390

中国药物警戒 ›› 2023, Vol. 20 ›› Issue (12): 1375-1381.
DOI: 10.19803/j.1672-8629.20230390

盐酸多奈哌齐片质量评价

关皓月, 刘年, 藄梦洁, 孙百浩, 刘雪婧, 胡钖, 牛剑钊^*

中国食品药品检定研究院化学药品检定所，北京 100050

收稿日期:2023-06-16 出版日期:2023-12-15 发布日期:2023-12-15
通讯作者: ^*牛剑钊,男,硕士,副主任药师,化学药品质量研究。E-mail：njz@nifdc.org.cn
作者简介:关皓月,女,硕士,副主任药师,化学药品质量研究。
基金资助:
国家重点研发计划（2020YFE0201700）

Quality analysis of donepezil hydrochloride tablet

GUAN Haoyue, LIU Nian, QI Mengjie, SUN Baihao, LIU Xuejing, HU Yang, NIU Jianzhao^*

Naitonal Food and Drug Control, Institute of drug Control, Beijing 100050, China

Received:2023-06-16 Online:2023-12-15 Published:2023-12-15

摘要/Abstract

摘要： 目的评价盐酸多奈哌齐片的质量现状,为其生产质控和有效监管提供参考。方法按照国家药品抽检计划要求,采用各执行标准检验结合探索性研究的方式,对包括原研企业在内的7家生产企业的140批次样品进行质量考察。结果按执行标准检验全部合格,普通国产制剂与参比制剂及通过仿制药一致性评价的产品,在有关物质和含量等方面仍存在一定的质量差异。现行片剂各执行标准中,检验项目不同,检验方法和标准限度不统一。结论国内盐酸多奈哌齐片的总体质量趋好,仿制制剂质量水平与参比制剂仍存在差距。现行标准基本可行,但仍需完善和提高,以控制生产过程,提升药品质量。

关键词: 盐酸多奈哌齐, 药品抽检, 质量分析, 参比制剂, 仿制药, 一致性评价

Abstract: Objective To evaluate the quality status of donepezil hydrochloride for providing reference for its production, quality control and supervision. Methods According to the general requirements of inspection program, the statutory methods combined with the exploratory studies were used to evaluate the quality condition of 140 batches of donepezil hydrochloride produced by 7 manufactures. Results All samples were inspected according to the executive standards, and the qualiﬁed rate was 100%. But there were some quality differences in related substances and assay among generic drugs, RLD (reference listed drug), and products passing the consistency evaluation. The legal standards were various with different test items and the methods and limits of standards were not uniformed. Conclusion The overall quality of donepezil hydrochloride was good, but there was still a gap between the quality level of the generic drug and the RLD. The current standard is basically feasible,but it still needs to be perfected to control the production process and improve the quality of preparations.

Key words: donepezil hydrochloride, drug random inspection, quality analysis, reference listed drug, generic drug, consistency evaluation

中图分类号:

R994.1

关皓月, 刘年, 藄梦洁, 孙百浩, 刘雪婧, 胡钖, 牛剑钊. 盐酸多奈哌齐片质量评价[J]. 中国药物警戒, 2023, 20(12): 1375-1381.

GUAN Haoyue, LIU Nian, QI Mengjie, SUN Baihao, LIU Xuejing, HU Yang, NIU Jianzhao. Quality analysis of donepezil hydrochloride tablet[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1375-1381.

参考文献

[1] REN RJ, YIN P, WANG ZH, et al.Chinese Alzheimer's Disease Report 2021[J]. Journal of diagnostics concepts and practice(诊断学理论与实践), 2021, 20(4): 317-337.
[2] National Medical Products Administration. Circular of reference preparations for Generic drugs by NMPA (eleventh batch)[EB/OL].(2017-12-29)[2023-09-13].https://www.nmpa.gov.cn/yaopin/ypggtg/ypqtgg/20171229145401334.html.
[3] Chinese Pharmacopoeia Comission.Chinese Pharnlacopoeia 2020 II (中华人民共和国药典二部)[M].Beijing: China Medical Science Press, 2020, 1148-1149.
[4] US Pharmacopoeia Comission. Pharmacopoeia Comission(美国药典)[EB/OL].(2017-05-10)[2023-11-26]. https://www.thefreedictionary. com/pharmacopoeial.
[5] Pharmaceuticals and Medical Devices Agency.The Japanese PharmacopoeiaJPXVII.[EB/OL].(2016-03-07)[2022-02-13].https://www.pmda.go.jp/PmdaSearch/iyakuSearch/
[6] EDQM.European Pharmacopoeia 10.1.[EB/OL](2019-07-03)[2022-02-13]. https://store.edqm.eu/b2c_deqm/app/displayApp/(cpgsize= 0&layout= 7.0-68_6_9_3&uiarea=3&carea=0000000067&cpgnum=1)/.do?rf=y
[7] Center for Drug Evaluation, NMPA.Technical guidelines for the study of nitrosamines in chemical drugs (trial implementation)[EB/OL].(2020-05-08)[2023-08-25].https://www.cde.org.cn/main/news/viewInfoCommon/776b663787ec5a60ac744071c3714d5a.
[8] FENG XL, ZHU HM.Genotoxicity Assessment and Limit Study of Azilsartan Related Compounds[J] .Chin J Mod Appl Pharm(中国现代应用药学), 2023, 40(10): 1313-1316.
[9] FENG XL, ZHU HM.(Quantitative) structure-activity relationships to predict the genotoxicity of rivaroxaban organic impurities[J] .Chin J Mod Appl Pharm(中国现代应用药学), 2021,38(11):1289-1293.
[10] RASINGER JD, FRENZEL F, BRAEUNING A, et al.Use of (Q)SAR genotoxicity predictions and fuzzy multicriteria decision-making for priority ranking of ethoxyquin transformation products[J]. Environ Int, 2022 (158):106875.
[11] CAYLEY AN, FOSTER RS, BRIGO A, et al.Assessing the utility of common arguments used in expert review of in silico predictions as part of ICH M7 assessments[J]. Regul Toxicol Pharmacol, 2023 (144): 105490.
[12] Manne Satyanarayana Reddy, Sajja Eswaraiah, Mathad Vijayavitthal.Novel crytalline form VI of donepezil hydrochloride and process for the properation thereof: US, 2004/0229914 AI[P].2004-11-18.
[13] Tomiyama Tadashi, Aota nobuo,Akamatsu Hiroshi.Polymorfhic crystal of donepezil and process for the producing the same: WO, 2010/071216 AI[P]. 2010-06-24.

盐酸多奈哌齐片质量评价

Quality analysis of donepezil hydrochloride tablet

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 7

编辑推荐

Metrics

[1]	贾茵茵, 张财树, 周颖, 刘丽, 耿颖, 魏宁漪, 钮思静, 陈华, 许卉. 吸入制剂微细粒子空气动力学粒径分布评价方法研究[J]. 中国药物警戒, 2024, 21(2): 141-146.
[2]	傅孟君, 姚慧慧, 朱克旭, 王馨远, 姚尚辰. 吲达帕胺片仿制药及其参比制剂溶出曲线比对评价研究[J]. 中国药物警戒, 2023, 20(7): 763-768.
[3]	刘静, 刘燕, 郑笑为, 汪祺, 何风艳, 王菲菲, 王亚丹, 何轶, 聂黎行, 胡晓茹, 戴忠, 马双成. 基于国家药品抽检的骨刺片质量分析[J]. 中国药物警戒, 2023, 20(3): 292-295.
[4]	肖钦钦, 陈希, 段和祥, 张银花, 刘绪平, 王晨. 乳酸左氧氟沙星氯化钠注射液杂质谱研究[J]. 中国药物警戒, 2022, 19(5): 527-531.
[5]	宋金春, 侯亚婷. 甲硝唑片仿制药在不同介质中的体外溶出度比较[J]. 中国药物警戒, 2017, 14(1): 27-31.
[6]	张翔, 宋金春, 陈莉. 吲达帕胺片仿制药与原研药的溶出度一致性评价[J]. 中国药物警戒, 2016, 13(7): 403-407.
[7]	刘斌, 翟伟, 马宁, 周立新. 医疗器械不良事件报告表质量评价方法探索[J]. 中国药物警戒, 2011, 8(3): 165-167.